Latest Breaking News On - Biotheus inc - Page 4 : comparemela.com

BioNTech SE: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J P Morgan Healthcare Conference

BioNTech SE: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J P Morgan Healthcare Conference
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoGenmab saUgur sahinFosun pharmaGenentech incDrug administrationDuality biologics suzhou coPfizer incBiotheus incRoche groupHealthcare conferenceInvestor relationsFull yearFourth quarterSelected pipeline updates

Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications

Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Fosun pharmaJun baoXiaolin liuRoche groupPrnewswire biotheus incGoby globalBiotheus incBispecific antibody candidateGreater chinaAntitrust improvements actNew technologiesDuality biologics

BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update

06.11.2023 - Positive clinical data updates across multiple drug classes including antibody-drug conjugate (ADC) candidates BNT323/DB-1303, BNT325/DB-1305, CAR-T candidate BNT211, T cell therapy candidate BNT221 and mRNA cancer vaccine candidate BNT116Progress .

United kingdomUnited statesSouth koreaFosun pharmaRoche tecentriqRegeneron libtayoBiontech fixvacUgur sahinJens holsteinGerman central bank deutsche bundesbankDuality biologics suzhou coMedilink therapeutics suzhou co ltdPfizer japan co ltdCoalition for epidemic preparedness innovationsRoche groupBiontech group

BioNTech SE: BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update

BioNTech SE: BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSouth koreaJens holsteinUgur sahinBiontech fixvacFosun pharmaRoche tecentriqRegeneron libtayoMpox programGerman central bank deutsche bundesbankDuality biologics suzhou coEuropean society of medical oncologyDays missionMedilink therapeutics suzhou co ltdRegeneron pharmaceuticals inc

Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech

/PRNewswire/ Biotheus Inc. ("Biotheus"), a clinical-stage biotech company dedicated to the discovery and development of biologics for oncology and.

Jun baoXiaolin liuBiotheus incChief executive officer